Pulmonary endarterectomy for pulmonary hypertension from septic emboli

William Crosland; Mustafa Ahmed; Julian Booker; Keith Wille; Satinder Singh; Thomas Winokur; David McGiffin

doi:10.1016/j.athoracsur.2014.06.109

Pulmonary endarterectomy for pulmonary hypertension from septic emboli

Ann Thorac Surg. 2015;99(5):1814-6. doi: 10.1016/j.athoracsur.2014.06.109.

Authors

William Crosland¹, Mustafa Ahmed¹, Julian Booker¹, Keith Wille¹, Satinder Singh², Thomas Winokur³, David McGiffin⁴

Affiliations

¹ Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama.
² Department of Radiology, The University of Alabama at Birmingham, Birmingham, Alabama.
³ Department of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama.
⁴ Department of Cardiothoracic Surgery and Transplantation, The Alfred Hospital and Monash University, Melbourne, Victoria, Australia. Electronic address: d.mcgiffin@alfred.org.au.

PMID: 25952218
DOI: 10.1016/j.athoracsur.2014.06.109

Abstract

Pulmonary endarterectomy (PEA) can significantly increase long-term survival in patients with chronic thromboembolic pulmonary hypertension; however, the role of PEA for chronic thromboembolic pulmonary hypertension due to pulmonary valve endocarditis is controversial. A critically ill 61-year-old man with intractable right ventricular heart failure was found to have chronic thromboembolic pulmonary hypertension due to Streptococcus bovis pulmonary valve endocarditis and underwent successful pulmonary valve replacement and PEA. The successful outcome in this case suggests that PEA should be considered in patients with this condition.

Publication types

Case Reports

MeSH terms

Endarterectomy*
Endocarditis, Bacterial / complications*
Humans
Hypertension, Pulmonary / etiology*
Male
Middle Aged
Pulmonary Embolism / complications*
Pulmonary Embolism / microbiology
Pulmonary Embolism / surgery*
Streptococcal Infections / complications*
Streptococcus bovis*